Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMERGE: CDX-011 in GPNMB-expressing advanced breast cancer
NCT01156753Phase 2Completed
- Sponsor
- Celldex Therapeutics
- Start
- Jul 2010
- Primary completion
- Oct 2012
- Countries
- 1
01
Overview
A Phase 2 trial of glembatumumab vedotin in breast cancer, sponsored by Celldex Therapeutics. Started Jul 2010; status: completed.
02
Drugs
glembatumumab vedotin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01156753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01156753.